ANALIZE MEDICALE DE LABORATOR
Aici gasiti analizele medicale grupate pe categorii precum si detalii generale si specifice pentru categoriile respective.
Selectati o categorie din lista de mai jos:
Solutie antistress!
Construieste poduri :)
Prinde pisica neagra :)
Brava System Used In New Study 'Breast Augmentation With Grafting Of Liposuctioned Fat: A Safe And Effective Procedure'
The Brava System, the only clinically
proven device for non-surgical breast augmentation, is part of a leading
edge study that offers women a new minimally invasive option for breast
augmentation and reconstruction. The study, "Breast Augmentation With
Grafting of Liposuctioned Fat: A Safe and Effective Procedure," is being
conducted by Roger K. Khouri, M.D., Steven E. Chavoustie, M.D. and Macarena
Carretero, M.D. The preliminary findings will be presented today at the
American College of Obstetricians and Gynecologists (ACOG) 55th Annual
Clinical Meeting in San Diego. Until now, women have had two
clinically-proven options available for breast augmentation: surgical
breast implants and a non-surgical enhancement through the use of an
external tissue expansion device. In this study, physicians utilize
autologous fat to reshape and augment the breasts.
Historically, autologous fat injection in breast augmentation was
controversial and banned in 1987 by the American Society of Plastic and
Reconstructive Surgeon's Ad-Hoc Committee on New Procedures. The
Committee's opinion stipulated that much of the injected fat would not
survive and the physiologic response to fat necrosis was scarring and
calcification, thus making mammography difficult to interpret. Today, with
advancements in breast imaging, the harvesting of tissue, more refined
surgical cannulas and improved preparation of the recipient graft site,
this procedure is now a viable option for breast augmentation. For this
procedure, patients are treated pre-operatively and post-operatively using
Brava, an external tissue expander, to prepare, and later stent, the
recipient site. The single-stage, large-volume lipotransfer breast
augmentation notes a graft survival rate of 90% in the prepared, expanded,
hypervascularized tissue bed. While the study is on-going, the 25 reported
patients who have gone through the process have had increases of between 90
to 300 ml per breast (approximately 1 to 2-1/2 cup sizes). "OB/GYNs are
frequently asked by their patients about breast augmentation and
reconstruction", says Dr. Chavoustie. "Traditionally, there were only two
alternatives we could offer our patients, breast implant surgery or a
non-surgical breast expansion device. Now, this new procedure, which is
both safe and effective, offers the benefit of a natural (autologous) fat
filler, which will not affect breast imaging, and has the added benefit of
target site liposuctioning. Dr. Chavoustie goes on to explain, "Not only
are we looking at this new cutting edge procedure as a cosmetic
alternative, but also for future reconstructive applications for patients
with status-post lumpectomy filling defects or breast asymmetry."
Dr. Steven Chavoustie, Physician Director of Research and Development
at Brava, LLC, will be present at the ACOG's Annual Clinical Meeting,
Poster Presentation #98, to discuss the study in more detail on Tuesday
afternoon, May 8th. He will also be available at booth #436 (Brava, LLC)
Monday, May 7th and Wednesday, May 9th.
For more information about the Brava System, please visit the Brava Web
site, http://www.brava.com.
About the Study Investigators
Roger K. Khouri, M.D., is a noted plastic and reconstructive surgeon
practicing in Miami, FL and the inventor of the Brava System. Prior to
co-founding Brava, LLC, Dr. Khouri held professional and fellowship
positions at Brown, Harvard, New York and Washington Universities.
Steven E. Chavoustie, M.D., FACOG, is the Physician Director of Medical
Research and Development at Brava, LLC and a Voluntary Assistant Professor
of Obstetrics and Gynecology and Medical Education at the University of
Miami, Miller School of Medicine.
Macarena Carretero, M.D., is a practicing radiologist and co-director
at the Breast Health Center in South Miami, FL, and has served over 20
years as a member of the American Society of Breast Disease.
About Brava, LLC
Brava, LLC, founded in 1999, is a medical device manufacturer. Products
include the Brava Breast Enhancement System. Brava, LLC headquarters are
located at 14221 S.W. 142nd Street, Miami, FL 33186.
Brava, LLC
http://www.brava.com
Brava sistem utilizate în studiu nou "sân, cu adaos de altoire Liposuctioned gras: o procedurã sigurã ºi eficientã" - Brava System Used In New Study 'Breast Augmentation With Grafting Of Liposuctioned Fat: A Safe And Effective Procedure' - articole medicale engleza - startsanatate